In vivo bioluminescence for tracking cell fate and function

Area of Science:

• Biomedical imaging
• Cellular biology
• Regenerative medicine

Background:

• Tracking cell fate and function in vivo is crucial for developing effective cardiac injury therapies.
• Bioluminescence imaging (BLI) offers real-time monitoring of physiological processes, including cell survival and gene expression.
• BLI's high sensitivity in rodents, due to low background luminescence and absence of endogenous luciferase, makes it ideal for in vivo studies.

Purpose of the Study:

• To highlight the utility of Bioluminescence Imaging (BLI) in tracking cell fate and function for cardiac injury research.
• To demonstrate BLI's role in monitoring stem cell behavior in vivo, including survival, migration, and potential tumorigenicity.
• To showcase BLI as a tool for optimizing drug and gene therapies through semiquantitative gene expression measurements.

Main Methods:

• Utilizing Bioluminescence Imaging (BLI) for in vivo monitoring of cellular processes.
• Applying BLI for longitudinal tracking of cell survival and migration in animal models.
• Employing BLI for semiquantitative assessment of gene expression in therapeutic interventions.

Main Results:

• BLI enables sensitive, real-time monitoring of cell survival, migration, immunogenicity, and tumorigenicity in vivo.
• The technique allows for semiquantitative measurements of gene expression, facilitating therapy optimization.
• BLI provides rapid, reproducible, and quantitative assessment of physiological processes and therapeutic intervention outcomes.

Conclusions:

• Bioluminescence imaging is a powerful tool for advancing cardiac injury research and therapy development.
• BLI enhances understanding of stem cell biology in vivo, crucial for regenerative medicine applications.
• This imaging modality supports the optimization and evaluation of novel drug and gene therapies for cardiac conditions.